KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Long-Term Investments (2017 - 2022)

Palvella Therapeutics (PVLA) has disclosed Long-Term Investments for 5 consecutive years, with $20.3 million as the latest value for Q2 2022.

  • On a quarterly basis, Long-Term Investments changed N/A to $20.3 million in Q2 2022 year-over-year; TTM through Jun 2022 was $20.3 million, a N/A change, with the full-year FY2019 number at $28.6 million, changed N/A from a year prior.
  • Long-Term Investments was $20.3 million for Q2 2022 at Palvella Therapeutics, up from $1.9 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $38.9 million in Q1 2019 to a low of $700000.0 in Q2 2018.
  • A 4-year average of $14.0 million and a median of $8.4 million in 2019 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 1406.93% in 2019, then crashed 84.37% in 2020.
  • Palvella Therapeutics' Long-Term Investments stood at $700000.0 in 2018, then skyrocketed by 3992.0% to $28.6 million in 2019, then plummeted by 76.43% to $6.8 million in 2020, then skyrocketed by 200.58% to $20.3 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Long-Term Investments are $20.3 million (Q2 2022), $1.9 million (Q1 2022), and $6.8 million (Q3 2020).